Your browser doesn't support javascript.
loading
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
King, Amanda L; Roche, Kayla N; Leeper, Heather E; Vera, Elizabeth; Mendoza, Tito; Mentges, Kelly; Acquaye, Alvina A; Adegbesan, Kendra; Boris, Lisa; Burton, Eric; Choi, Anna; Grajkowska, Ewa; Kunst, Tricia; Levine, Jason; Lollo, Nicole; Miller, Hope; Panzer, Marissa; Penas-Prado, Marta; Pillai, Valentina; Polskin, Lily; Reyes, Jennifer; Sahebjam, Solmaz; Stockdill, Macy; Theeler, Brett J; Wu, Jing; Gilbert, Mark R; Armstrong, Terri S.
Afiliación
  • King AL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Roche KN; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Leeper HE; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Vera E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Mendoza T; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Mentges K; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc.
  • Acquaye AA; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Adegbesan K; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Boris L; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc.
  • Burton E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Choi A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Grajkowska E; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc.
  • Kunst T; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc.
  • Levine J; Center for Cancer Research Office of Information Technology, National Cancer Institute, National Institutes of Health.
  • Lollo N; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc.
  • Miller H; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Panzer M; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc.
  • Penas-Prado M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Pillai V; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc.
  • Polskin L; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc.
  • Reyes J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Sahebjam S; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Stockdill M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Theeler BJ; Uniformed Services University of the Health Sciences.
  • Wu J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
  • Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health.
Res Sq ; 2023 Jan 31.
Article en En | MEDLINE | ID: mdl-36789426

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Qualitative_research Idioma: En Revista: Res Sq Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Qualitative_research Idioma: En Revista: Res Sq Año: 2023 Tipo del documento: Article